1176 related articles for article (PubMed ID: 18334831)
41. [Univariate and multivariate regression analyses of recurrence and metastasis of colon cancer after radical resection].
Ren JQ; Zhou ZW; Wan DS; Lu ZH; Chen G; Wang GQ; Tang SX; Wang JJ
Ai Zheng; 2006 May; 25(5):591-5. PubMed ID: 16687080
[TBL] [Abstract][Full Text] [Related]
42. Microsatellite instability in sporadic colon carcinomas has no independent prognostic value in a Belgian study population.
Deschoolmeester V; Van Damme N; Baay M; Claes K; Van Marck E; Baert FJ; Wuyts W; Cabooter M; Weyler J; Vermeulen P; Lardon F; Vermorken JB; Peeters M
Eur J Cancer; 2008 Oct; 44(15):2288-95. PubMed ID: 18707864
[TBL] [Abstract][Full Text] [Related]
43. Prognostic significance of circulating antibodies against carcinoembryonic antigen (anti-CEA) in patients with colon cancer.
Albanopoulos K; Armakolas A; Konstadoulakis MM; Leandros E; Tsiompanou E; Katsaragakis S; Alexiou D; Androulakis G
Am J Gastroenterol; 2000 Apr; 95(4):1056-61. PubMed ID: 10763959
[TBL] [Abstract][Full Text] [Related]
44. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
[TBL] [Abstract][Full Text] [Related]
45. Proliferating cell nuclear antigen as a prognostic factor after total mesorectal excision of stage II-III rectal cancer.
Huh JW; Kim HR; Kim YJ
Ann Surg Oncol; 2009 Jun; 16(6):1494-500. PubMed ID: 19267156
[TBL] [Abstract][Full Text] [Related]
46. [Prognostic criteria and risk groups in colorectal cancer].
Mentges B; Brückner R
Wien Med Wochenschr; 1988 Jul; 138(13):317-22. PubMed ID: 3188544
[TBL] [Abstract][Full Text] [Related]
47. Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer.
Wang Y; Jatkoe T; Zhang Y; Mutch MG; Talantov D; Jiang J; McLeod HL; Atkins D
J Clin Oncol; 2004 May; 22(9):1564-71. PubMed ID: 15051756
[TBL] [Abstract][Full Text] [Related]
48. Prospective study of intratumoral microvessel density, p53 expression and survival in colorectal cancer.
Vermeulen PB; Van den Eynden GG; Huget P; Goovaerts G; Weyler J; Lardon F; Van Marck E; Hubens G; Dirix LY
Br J Cancer; 1999 Jan; 79(2):316-22. PubMed ID: 9888475
[TBL] [Abstract][Full Text] [Related]
49. [Prognostic factors in colorectal cancer].
Tominaga T
Gan To Kagaku Ryoho; 1988 Aug; 15(8):2202-8. PubMed ID: 3408254
[TBL] [Abstract][Full Text] [Related]
50. [Multivariate regressive analysis of prognosis of liver metastases from colorectal cancer].
Zhou ZW; Ren JQ; Wan DS; Chen G; Lu ZH; Pan ZZ; Li LR; Wu XJ; Ding PR
Ai Zheng; 2006 Sep; 25(9):1149-52. PubMed ID: 16965660
[TBL] [Abstract][Full Text] [Related]
51. Clinical and pathological analyses of patients with a family history of colorectal cancer. Registry Committee, Japanese Research Society for Cancer of the Colon and Rectum.
Jpn J Clin Oncol; 1993 Dec; 23(6):342-9. PubMed ID: 8283787
[TBL] [Abstract][Full Text] [Related]
52. Matrix metalloproteinase-9 expression correlated with tumor response in patients with locally advanced rectal cancer undergoing preoperative chemoradiotherapy.
Unsal Kilic D; Uner A; Akyurek N; Erpolat P; Dursun A; Pak Y
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):196-203. PubMed ID: 17071013
[TBL] [Abstract][Full Text] [Related]
53. Distribution of lymph node metastasis is a prognostic index in patients with stage III colon cancer.
Kobayashi H; Ueno H; Hashiguchi Y; Mochizuki H
Surgery; 2006 Apr; 139(4):516-22. PubMed ID: 16627061
[TBL] [Abstract][Full Text] [Related]
54. Colorectal carcinoma: importance of clinical and pathological factors in survival.
Deans GT; Patterson CC; Parks TG; Spence RA; Heatley M; Moorehead RJ; Rowlands BJ
Ann R Coll Surg Engl; 1994 Jan; 76(1):59-64. PubMed ID: 8117023
[TBL] [Abstract][Full Text] [Related]
55. Prognostic significance of receptor-binding cancer antigen expressed on SiSo cells (RCAS1) expression in relation to cadherin expression in patients with colorectal carcinoma.
Tsujitani S; Saito H; Honboh T; Ataka M; Tanida T; Makino M; Ikeguchi M
Dis Colon Rectum; 2007 Aug; 50(8):1241-9. PubMed ID: 17429708
[TBL] [Abstract][Full Text] [Related]
56. CEA as a prognostic factor in colorectal cancer.
Filella X; Molina R; Piqué JM; Grau JJ; Garcia-Valdecasas JC; Biete A; Novell F; Astudillo E; Bordas JM; Campo E
Anticancer Res; 1994; 14(2B):705-8. PubMed ID: 8010730
[TBL] [Abstract][Full Text] [Related]
57. Tumor budding as an index to identify high-risk patients with stage II colon cancer.
Nakamura T; Mitomi H; Kanazawa H; Ohkura Y; Watanabe M
Dis Colon Rectum; 2008 May; 51(5):568-72. PubMed ID: 18286339
[TBL] [Abstract][Full Text] [Related]
58. Elevated preoperative serum carcinoembrionic antigen level may be an effective indicator for needing adjuvant chemotherapy after potentially curative resection of stage II colon cancer.
Ogata Y; Murakami H; Sasatomi T; Ishibashi N; Mori S; Ushijima M; Akagi Y; Shirouzu K
J Surg Oncol; 2009 Jan; 99(1):65-70. PubMed ID: 18942720
[TBL] [Abstract][Full Text] [Related]
59. High telomerase activity is an independent prognostic indicator of poor outcome in colorectal cancer.
Tatsumoto N; Hiyama E; Murakami Y; Imamura Y; Shay JW; Matsuura Y; Yokoyama T
Clin Cancer Res; 2000 Jul; 6(7):2696-701. PubMed ID: 10914712
[TBL] [Abstract][Full Text] [Related]
60. [Prognostic value of cyclin E and its relation to blood vessel invasion in rectal cancer].
Zhou YJ; Wan FL; Yao LH; Feng LY
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Mar; 11(2):167-71. PubMed ID: 18344087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
